BWA
TLOG

Burt Wealth Advisors’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Burt Wealth Advisors’s Portfolio TLOG Stock Details TLOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,625
Closed – – 436
2017
Q2 		$0 Hold
2,625
– – ﹤0.01% 437
2017
Q1 		$0 Hold
2,625
– – ﹤0.01% 414
2016
Q4 		$1K Hold
2,625
– – ﹤0.01% 400
2016
Q3 		$1K Hold
2,625
– – ﹤0.01% 402
2016
Q2 		$1K Hold
2,625
– – ﹤0.01% 410
2016
Q1 		$1K Hold
2,625
– – ﹤0.01% 602
2015
Q4 		$4K Hold
2,625
– – ﹤0.01% 414
2015
Q3 		$4K Hold
2,625
– – 0.01% 329
2015
Q2 		$6K Hold
2,625
– – 0.01% 310
2015
Q1 		$11K Hold
2,625
– – 0.01% 237
2014
Q4 		$13K Buy
+2,625
New +$11.7K 0.01% 218

Burt Wealth Advisors's TLOG Position: Q3 2017 in Review

Burt Wealth Advisors sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q3 2017, closing a stake of 2,625 shares.

Burt Wealth Advisors first reported a position in TLOG in Q4 2014 and held it in 11 quarters. The position peaked at $13K in Q4 2014. 1 fund tracked by Wall St. Rank holds TLOG as of Q3 2017.

  • Burt Wealth Advisors reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q3 2017 after selling out during the quarter.
  • Burt Wealth Advisors sold 2,625 TetraLogic Pharmaceuticals Corporation shares in Q3 2017.
  • Burt Wealth Advisors first reported a position in TetraLogic Pharmaceuticals Corporation in Q4 2014 and held it in 11 quarters.
  • Burt Wealth Advisors's TetraLogic Pharmaceuticals Corporation position peaked at $13K in Q4 2014.
  • 1 fund tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q3 2017.

Based on Burt Wealth Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.